Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 1167468Erstellt: 26. Oktober 2026

(5R)-3-[3-fluoro-4-(3-hydroxyazetidin-1-yl)phenyl]-5-(isoxazol-3-yloxymethyl)oxazolidin-2-one → 3-(3-Fluoro-4-(2-methyl-imidazol-1-yl)phenyl)-5(r)-(isoxazol-3-yloxymethyl)oxazolidin-2-one

https://huagongshe.com/reaction/1167468

Reaktionsgleichung

Beteiligte Stoffe

RolleNameHCIDEinwaage
Edukt(5R)-3-[3-fluoro-4-(3-hydroxyazetidin-1-yl)phenyl]-5-(isoxazol-3-yloxymethyl)oxazolidin-2-oneHCID 497421—
Edukt(5R)-3-(3-Fluoro-4-(2-methylimidazol-1-yl)phenyl)-5-hydroxymethyloxazolidin-2-oneHCID 21356557—
Produkt3-(3-Fluoro-4-(2-methyl-imidazol-1-yl)phenyl)-5(r)-(isoxazol-3-yloxymethyl)oxazolidin-2-oneHCID 69983189—

Reaktionsschritte

Using essentially the same procedure as for the intermediate of Example 65, but starting with 3-(3-fluoro-4-(2-methyl-imidazol-1-yl)phenyl)-5(R)-hydroxymethyloxazolidin-2-one (202 mg, 0.69 mmol), and purifying by chromatography on a 10 g silica Mega Bond Elut® column, eluting with a gradient increasing in polarity from 0 to 2.5% MeOH in dichloromethane, the title compound was prepared (137 mg).

Herkunft & Nachweise

DOI10.6084/m9.figshare.5104873.v1
PatentnummerUS06617339B1
Quelldatensatzuspto-grants-2003_09
ORD IDord-ad97199a624f4a19942add03c6b27245
Quellennotizuspto-grants-2003_09